(Q36811486)

16 August 2017

Temsirolimus therapy in a patient with lung adenocarcinoma harboring an FBXW7 mutation (English)

1 reference

16 August 2017

1 reference

Liza C Villaruz

1

1 reference

16 August 2017

Mark A Socinski

series ordinal

2

1 reference

16 August 2017

language of work or name

1 reference

1 December 2013

1 reference

16 August 2017

1 reference

16 August 2017

83

1 reference

16 August 2017

2

1 reference

16 August 2017

300-301

1 reference

Personalized medicine in lung cancer: what we need to know.

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4836187

FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4836187

FBXW7/hCDC4 is a general tumor suppressor in human cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4836187

Somatic mutation of hCDC4 gene is rare in lung adenocarcinomas.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4836187

Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4836187

10.1016/J.LUNGCAN.2013.11.018

5 September 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

24360397

1 reference